Artículos por temáticas

Spasticity: pathophysiology, evaluation and management.

Kheder A, Nair KP.

Pract Neurol. 2012 Oct;12(5):289-98. doi: 10.1136/practneurol-2011-000155. Review.

Obturator neurolysis using 65% alcohol for adductor muscle spasticity.

Ghai A, Sangwan SS, Hooda S, Kiran S, Garg N.

Saudi J Anaesth. 2012 Jul;6(3):282-4. doi: 10.4103/1658-354X.101223.

Development of a disease-specific health-related quality of life questionnaire for patients with post-stroke spasticity.

Zhang Y, Liu B, Liu Z, Wang Y, Zhao H, Zi M, Wang L, Liu H, Chen Z, Xie Y.

J Tradit Chin Med. 2012 Dec;32(4):674-8.

Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticity.

Doan QV, Brashear A, Gillard PJ, Varon SF, Vandenburgh AM, Turkel CC, Elovic EP.

PM R. 2012 Jan;4(1):4-10. doi: 10.1016/j.pmrj.2011.10.001.

Assessing competency in spasticity management: a method of development and assessment.

Escaldi SV, Cuccurullo SJ, Terzella M, Petagna AM, Strax TE.

Am J Phys Med Rehabil. 2012 Mar;91(3):243-53. doi: 10.1097/PHM.0b013e31823c73bf.

Combinational spinal GAD65 gene delivery and systemic GABA-mimetic treatment for modulation of spasticity.

Kakinohana O, Hefferan MP, Miyanohara A, Nejime T, Marsala S, Juhas S, Juhasova J, Motlik J, Kucharova K, Strnadel J, Platoshyn O, Lazar P, Galik J, Vinay L, Marsala M.

PLoS One. 2012;7(1):e30561. doi: 10.1371/journal.pone.0030561.

Focal muscle vibration in the treatment of upper limb spasticity: a pilot randomized controlled trial in patients with chronic stroke.

Caliandro P, Celletti C, Padua L, Minciotti I, Russo G, Granata G, La Torre G, Granieri E, Camerota F.

Arch Phys Med Rehabil. 2012 Sep;93(9):1656-61. doi: 10.1016/j.apmr.2012.04.002.

Sativex® in multiple sclerosis spasticity: a cost-effectiveness model.

Slof J, Gras A.

Expert Rev Pharmacoecon Outcomes Res. 2012 Aug;12(4):439-41. doi: 10.1586/erp.12.40.

[Clinical effect of ultrasound combined with anatomy-measure guidance botulinum toxin type A injection in poststroke patients with spasticity].

JIANG L, WEI XM, DOU ZL, LI X, WANG QY, LAN Y, HU XQ, ZHENG HQ.

Zhonghua Yi Xue Za Zhi. 2012 Apr 17;92(15):1045-8. Chinese.

Weight changes in children receiving intrathecal baclofen for the treatment of spasticity.

Pritula SL, Fox MA, Ayyangar R.

J Pediatr Rehabil Med. 2012;5(3):197-201.

Unilateral ankle dorsiflexor spasticity: an uncommon, disabling complication of transverse myelitis.

Mazlan M, Hamzah N, Ramakrishnan K.

Arch Med Sci. 2012 Nov 9;8(5):939-41. doi: 10.5114/aoms.2012.28594. No abstract available.

Spasticity in children with non-progressive brain disorders.

Ward T.

Nurs Times. 2012 Nov 20-26;108(47):23. No abstract available.

Neurobiological perspective of spasticity as occurs after a spinal cord injury.

Roy RR, Edgerton VR.

Exp Neurol. 2012 May;235(1):116-22. doi: 10.1016/j.expneurol.2012.01.017. Review.

Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity.

Oreja-Guevara C.

Expert Rev Neurother. 2012 Apr;12(4 Suppl):3-8. doi: 10.1586/ern.12.11. Review.

Differential local spasticity in myocardial bridges.

Angelini P, Uribe C, Lozano P.

Tex Heart Inst J. 2012;39(3):384-8.